| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Lipid assay improves cardiovascular risk prediction
Answers from the Lab
Like cholesterol, ceramides are lipids associated with cardiovascular disease. In this test-specific episode of the "Answers From the Lab" podcast, Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay goes beyond standard testing to guide the management of patients with mildly to moderately high cholesterol.
"Ceramides are an excellent biomarker that will help identify persons who really are at a high risk for cardiovascular complications in the near future," Dr. Meeusen says.
Ceramide testing requires mass spectrometry. Compared with other advanced markers of cardiovascular risk, ceramides have significant predictive abilities.
"And the good news about ceramides is they respond to the same treatments you would use to lower cholesterol," Dr. Meeusen says.
Listen to learn more about Mayo Clinic Laboratories' MI-Heart Ceramides assay.
Note: Podcasts will not play back on Internet Explorer. Please use an alternative web browser, or listen from your mobile device on a preferred listening app.
CERAM | MI-Heart Ceramides, Plasma
Evaluating the risk of major adverse cardiovascular events within the next 1 to 5 years.
Patient Preparation: Patients should not be receiving Intralipid because it may cause false elevations in measured ceramides.
Collection Container/Tube: Lavender top (EDTA)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge, aliquot at least 1 mL of plasma into a plastic vial and freeze within 8 hours.
